Predictors of "brain fog" 1 year after COVID-19 disease.
Brain fog
COVID-19
Cognitive difficulties
Long COVID
Neurology
Journal
Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology
ISSN: 1590-3478
Titre abrégé: Neurol Sci
Pays: Italy
ID NLM: 100959175
Informations de publication
Date de publication:
Oct 2022
Oct 2022
Historique:
received:
07
06
2022
accepted:
18
07
2022
pubmed:
6
8
2022
medline:
17
9
2022
entrez:
5
8
2022
Statut:
ppublish
Résumé
Brain fog has been described up to 1 year after SARS-CoV-2 infection, notwithstanding the underlying mechanisms are still poorly investigated. In this study, we aimed to evaluate the prevalence of cognitive complaints at 1-year follow-up and to identify the factors related to persistent brain fog in COVID-19 patients. Out of 246 COVID patients, hospitalized from March 1st to May 31st, a sample of 137 patients accepted to be evaluated at 1 year from discharge, through a full clinical, neurological, and psychological examination, including the Montreal Cognitive Assessment (MoCA), impact of event scale-revised (IES-R), Zung self-rating depression scale (SDS), Zung self-rating anxiety scale (SAS), and fatigue severity scale (FSS). Subjects with prior cognitive impairment and/or psychiatric disorders were excluded. Patients with cognitive disorders exhibited lower MoCA score (22.9 ± 4.3 vs. 26.3 ± 3.1, p = 0.002) and higher IES-R score (33.7 ± 18.5 vs. 26.4 ± 16.3, p = 0.050), SDS score (40.9 ± 6.5 vs. 35.5 ± 8.6, p = 0.004), and fatigue severity scale score (33.6 ± 16.1 vs. 23.7 ± 12.5, p = 0.001), compared to patients without cognitive complaints. Logistic regression showed a significant correlation between brain fog and the self-rating depression scale values (p = 0.020), adjusted for age (p = 0.445), sex (p = 0.178), premorbid Cumulative Illness Rating Scale (CIRS) (p = 0.288), COVID-19 severity (BCRSS) (p = 0.964), education level (p = 0.784) and MoCA score (p = 0.909). Our study showed depression as the strongest predictor of persistent brain fog, adjusting for demographic and clinical variables. Wider longitudinal studies are warranted to better explain cognitive difficulties after COVID-19.
Identifiants
pubmed: 35930181
doi: 10.1007/s10072-022-06285-4
pii: 10.1007/s10072-022-06285-4
pmc: PMC9361921
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
5795-5797Informations de copyright
© 2022. Fondazione Società Italiana di Neurologia.
Références
Zhang X, Wang F, Shen Y et al (2021) Symptoms and health outcomes among survivors of COVID-19 infection 1 year after discharge from hospitals in Wuhan. China JAMA Netw Open 4:e2127403
doi: 10.1001/jamanetworkopen.2021.27403
Taquet M, Geddes JR, Husain M, Luciano S, Harrison PJ (2021) 6-month neurological and psychiatric outcomes in 236 379 survivors of COVID-19: a retrospective cohort study using electronic health records. Lancet Psychiatry 8:416–427
doi: 10.1016/S2215-0366(21)00084-5
Pilotto A, Cristillo V, Cotti Piccinelli S et al (2021) Long-term neurological manifestations of COVID-19: prevalence and predictive factors. Neurol Sci 42:4903–4907
doi: 10.1007/s10072-021-05586-4
Sollini M, Morbelli S, Ciccarelli M et al (2021) Long COVID hallmarks on [18F]FDG-PET/CT: a case-control study. Eur J Nucl Med Mol Imaging 48:3187–3197
doi: 10.1007/s00259-021-05294-3
Hugon J, Msika EF, Queneau M, Farid K, Paquet C (2022) Long COVID: cognitive complaints (brain fog) and dysfunction of the cingulate cortex. J Neurol 269:44–46
doi: 10.1007/s00415-021-10655-x
Hampshire A, Trender W, Chamberlain SR et al (2021) Cognitive deficits in people who have recovered from COVID-19. EClinicalMedicine 39:101044
doi: 10.1016/j.eclinm.2021.101044
Cristillo V, Pilotto A, Cotti Piccinelli S et al (2021) Age and subtle cognitive impairment are associated with long-term olfactory dysfunction after COVID-19 infection. J Am Geriatr Soc 69:2778–2780
doi: 10.1111/jgs.17296
Pilotto A, Masciocchi S, Volonghi I et al (2021) Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) encephalitis is a cytokine release syndrome: evidences from cerebrospinal fluid analyses. Clin Infect Dis 73:e3019–e3026
doi: 10.1093/cid/ciaa1933
Lupien SJ, Maheu F, Tu M, Fiocco A, Schramek TE (2007) The effects of stress and stress hormones on human cognition: implications for the field of brain and cognition. Brain Cogn 65:209–237
doi: 10.1016/j.bandc.2007.02.007
Fiorenzato E, Zabberoni S, Costa A, Cona G (2021) Cognitive and mental health changes and their vulnerability factors related to COVID-19 lockdown in Italy. PLoS ONE 16:e0246204
doi: 10.1371/journal.pone.0246204